Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain
- PMID: 10584033
- PMCID: PMC91773
- DOI: 10.1128/AEM.65.12.5631-5635.1999
Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain
Abstract
A novel bacteriocin-like substance produced by vaginal Lactobacillus salivarius subsp. salivarius CRL 1328 with activity against Enterococcus faecalis, Enterococcus faecium, and Neisseria gonorrhoeae was characterized. The highest level of production of this heat-resistant peptide or protein occurred during the late exponential phase. Its mode of action was shown to be bactericidal. L. salivarius subsp. salivarius CRL 1328 could be used for the design of a probiotic to prevent urogenital infections.
Figures
References
-
- Arihara K, Ogihara S, Mukai T, Itoh M, Kondo Y. Salivacin 140, a novel bacteriocin from Lactobacillus salivarius subsp. salicinius T140 active against pathogenic bacteria. Lett Appl Microbiol. 1996;22:420–424. - PubMed
-
- Baerheim S, Larsen E, Di Granes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infections in women. Scand J Prim Health Care. 1994;12:239–242. - PubMed
-
- Giori A, Torrani S, Dellaglio F, Bo G, Stola E, Bernuzzi L. Identification of vaginal lactobacilli from asymptomatic women. Microbiologica. 1987;10:377–384. - PubMed
-
- Guillilan S E. Beneficial interrelationships between certain microorganisms and humans: candidate microorganisms for use as dietary adjuncts. J Food Prot. 1979;42:164–167. - PubMed
-
- Havenaar R, Brink B T, Huis In’T Veld J H J. Selection of strains for probiotics use. In: Fuller R, editor. Probiotics. The scientific basis. London, England: Chapman & Hall; 1992. pp. 209–223.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
